Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2022-01-01–present
Source not stated
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2022-01-01–present
BIIB
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Voyager Therapeutics, Inc. (VYGR) | M.D., Ph.D. Chief Executive Officer, President, and Director | $674,903 | $2,508,370 |
| 2024 | Voyager Therapeutics, Inc. (VYGR) | M.D., Ph.D. Chief Executive Officer, President, and Director | $652,080 | $3,379,876 |
| 2021 | Biogen Inc. (BIIB) | Former Executive Vice President, Research & Development | $921,621 | $5,737,900 |
| 2020 | Biogen Inc. (BIIB) | Executive Vice President, Research & Development | $890,310 | $6,226,969 |
| 2019 | Biogen Inc. (BIIB) | Executive Vice President, Research & Development | $798,723 | $5,312,565 |
Earnings-call appearances and filed executive appointments or departures, newest first.
